IBDEI1FI ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,23112,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23112,1,3,0)
;;=3^Nonrheumatic aortic valve stenosis
;;^UTILITY(U,$J,358.3,23112,1,4,0)
;;=4^I35.0
;;^UTILITY(U,$J,358.3,23112,2)
;;=^5007174
;;^UTILITY(U,$J,358.3,23113,0)
;;=I35.2^^78^1000^18
;;^UTILITY(U,$J,358.3,23113,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23113,1,3,0)
;;=3^Nonrheumatic aortic valve stenosis w/ insufficiency
;;^UTILITY(U,$J,358.3,23113,1,4,0)
;;=4^I35.2
;;^UTILITY(U,$J,358.3,23113,2)
;;=^5007176
;;^UTILITY(U,$J,358.3,23114,0)
;;=I42.8^^78^1000^7
;;^UTILITY(U,$J,358.3,23114,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23114,1,3,0)
;;=3^Cardiomyopathies, other
;;^UTILITY(U,$J,358.3,23114,1,4,0)
;;=4^I42.8
;;^UTILITY(U,$J,358.3,23114,2)
;;=^5007199
;;^UTILITY(U,$J,358.3,23115,0)
;;=I48.91^^78^1000^3
;;^UTILITY(U,$J,358.3,23115,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23115,1,3,0)
;;=3^Atrial fibrillation, unspec
;;^UTILITY(U,$J,358.3,23115,1,4,0)
;;=4^I48.91
;;^UTILITY(U,$J,358.3,23115,2)
;;=^5007229
;;^UTILITY(U,$J,358.3,23116,0)
;;=I48.92^^78^1000^4
;;^UTILITY(U,$J,358.3,23116,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23116,1,3,0)
;;=3^Atrial flutter, unspec
;;^UTILITY(U,$J,358.3,23116,1,4,0)
;;=4^I48.92
;;^UTILITY(U,$J,358.3,23116,2)
;;=^5007230
;;^UTILITY(U,$J,358.3,23117,0)
;;=I49.3^^78^1000^23
;;^UTILITY(U,$J,358.3,23117,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23117,1,3,0)
;;=3^Ventricular premature depolarization
;;^UTILITY(U,$J,358.3,23117,1,4,0)
;;=4^I49.3
;;^UTILITY(U,$J,358.3,23117,2)
;;=^5007233
;;^UTILITY(U,$J,358.3,23118,0)
;;=I50.9^^78^1000^6
;;^UTILITY(U,$J,358.3,23118,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23118,1,3,0)
;;=3^CHF,Unspec
;;^UTILITY(U,$J,358.3,23118,1,4,0)
;;=4^I50.9
;;^UTILITY(U,$J,358.3,23118,2)
;;=^5007251
;;^UTILITY(U,$J,358.3,23119,0)
;;=I69.928^^78^1000^22
;;^UTILITY(U,$J,358.3,23119,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23119,1,3,0)
;;=3^Speech/lang deficits following unsp cerebvasc disease
;;^UTILITY(U,$J,358.3,23119,1,4,0)
;;=4^I69.928
;;^UTILITY(U,$J,358.3,23119,2)
;;=^5007557
;;^UTILITY(U,$J,358.3,23120,0)
;;=I69.910^^78^1000^5
;;^UTILITY(U,$J,358.3,23120,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23120,1,3,0)
;;=3^Attention/Concentration Deficit Following Cerebrvasc Disease
;;^UTILITY(U,$J,358.3,23120,1,4,0)
;;=4^I69.910
;;^UTILITY(U,$J,358.3,23120,2)
;;=^5138660
;;^UTILITY(U,$J,358.3,23121,0)
;;=I69.911^^78^1000^15
;;^UTILITY(U,$J,358.3,23121,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23121,1,3,0)
;;=3^Memory Deficit Following Cerebvasc Disease
;;^UTILITY(U,$J,358.3,23121,1,4,0)
;;=4^I69.911
;;^UTILITY(U,$J,358.3,23121,2)
;;=^5138661
;;^UTILITY(U,$J,358.3,23122,0)
;;=I69.912^^78^1000^24
;;^UTILITY(U,$J,358.3,23122,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23122,1,3,0)
;;=3^Visospatial Deficit Following Cerebvasc Disease
;;^UTILITY(U,$J,358.3,23122,1,4,0)
;;=4^I69.912
;;^UTILITY(U,$J,358.3,23122,2)
;;=^5138662
;;^UTILITY(U,$J,358.3,23123,0)
;;=I69.913^^78^1000^21
;;^UTILITY(U,$J,358.3,23123,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23123,1,3,0)
;;=3^Psychomotor Deficit Following Cerebvasc Disease
;;^UTILITY(U,$J,358.3,23123,1,4,0)
;;=4^I69.913
;;^UTILITY(U,$J,358.3,23123,2)
;;=^5138663
;;^UTILITY(U,$J,358.3,23124,0)
;;=I69.914^^78^1000^11
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1FI 3753 printed Nov 22, 2024@17:17:53 Page 2
IBDEI1FI ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,23112,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,23112,1,3,0)
+4 ;;=3^Nonrheumatic aortic valve stenosis
+5 ;;^UTILITY(U,$J,358.3,23112,1,4,0)
+6 ;;=4^I35.0
+7 ;;^UTILITY(U,$J,358.3,23112,2)
+8 ;;=^5007174
+9 ;;^UTILITY(U,$J,358.3,23113,0)
+10 ;;=I35.2^^78^1000^18
+11 ;;^UTILITY(U,$J,358.3,23113,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,23113,1,3,0)
+14 ;;=3^Nonrheumatic aortic valve stenosis w/ insufficiency
+15 ;;^UTILITY(U,$J,358.3,23113,1,4,0)
+16 ;;=4^I35.2
+17 ;;^UTILITY(U,$J,358.3,23113,2)
+18 ;;=^5007176
+19 ;;^UTILITY(U,$J,358.3,23114,0)
+20 ;;=I42.8^^78^1000^7
+21 ;;^UTILITY(U,$J,358.3,23114,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,23114,1,3,0)
+24 ;;=3^Cardiomyopathies, other
+25 ;;^UTILITY(U,$J,358.3,23114,1,4,0)
+26 ;;=4^I42.8
+27 ;;^UTILITY(U,$J,358.3,23114,2)
+28 ;;=^5007199
+29 ;;^UTILITY(U,$J,358.3,23115,0)
+30 ;;=I48.91^^78^1000^3
+31 ;;^UTILITY(U,$J,358.3,23115,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,23115,1,3,0)
+34 ;;=3^Atrial fibrillation, unspec
+35 ;;^UTILITY(U,$J,358.3,23115,1,4,0)
+36 ;;=4^I48.91
+37 ;;^UTILITY(U,$J,358.3,23115,2)
+38 ;;=^5007229
+39 ;;^UTILITY(U,$J,358.3,23116,0)
+40 ;;=I48.92^^78^1000^4
+41 ;;^UTILITY(U,$J,358.3,23116,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,23116,1,3,0)
+44 ;;=3^Atrial flutter, unspec
+45 ;;^UTILITY(U,$J,358.3,23116,1,4,0)
+46 ;;=4^I48.92
+47 ;;^UTILITY(U,$J,358.3,23116,2)
+48 ;;=^5007230
+49 ;;^UTILITY(U,$J,358.3,23117,0)
+50 ;;=I49.3^^78^1000^23
+51 ;;^UTILITY(U,$J,358.3,23117,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,23117,1,3,0)
+54 ;;=3^Ventricular premature depolarization
+55 ;;^UTILITY(U,$J,358.3,23117,1,4,0)
+56 ;;=4^I49.3
+57 ;;^UTILITY(U,$J,358.3,23117,2)
+58 ;;=^5007233
+59 ;;^UTILITY(U,$J,358.3,23118,0)
+60 ;;=I50.9^^78^1000^6
+61 ;;^UTILITY(U,$J,358.3,23118,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,23118,1,3,0)
+64 ;;=3^CHF,Unspec
+65 ;;^UTILITY(U,$J,358.3,23118,1,4,0)
+66 ;;=4^I50.9
+67 ;;^UTILITY(U,$J,358.3,23118,2)
+68 ;;=^5007251
+69 ;;^UTILITY(U,$J,358.3,23119,0)
+70 ;;=I69.928^^78^1000^22
+71 ;;^UTILITY(U,$J,358.3,23119,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,23119,1,3,0)
+74 ;;=3^Speech/lang deficits following unsp cerebvasc disease
+75 ;;^UTILITY(U,$J,358.3,23119,1,4,0)
+76 ;;=4^I69.928
+77 ;;^UTILITY(U,$J,358.3,23119,2)
+78 ;;=^5007557
+79 ;;^UTILITY(U,$J,358.3,23120,0)
+80 ;;=I69.910^^78^1000^5
+81 ;;^UTILITY(U,$J,358.3,23120,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,23120,1,3,0)
+84 ;;=3^Attention/Concentration Deficit Following Cerebrvasc Disease
+85 ;;^UTILITY(U,$J,358.3,23120,1,4,0)
+86 ;;=4^I69.910
+87 ;;^UTILITY(U,$J,358.3,23120,2)
+88 ;;=^5138660
+89 ;;^UTILITY(U,$J,358.3,23121,0)
+90 ;;=I69.911^^78^1000^15
+91 ;;^UTILITY(U,$J,358.3,23121,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,23121,1,3,0)
+94 ;;=3^Memory Deficit Following Cerebvasc Disease
+95 ;;^UTILITY(U,$J,358.3,23121,1,4,0)
+96 ;;=4^I69.911
+97 ;;^UTILITY(U,$J,358.3,23121,2)
+98 ;;=^5138661
+99 ;;^UTILITY(U,$J,358.3,23122,0)
+100 ;;=I69.912^^78^1000^24
+101 ;;^UTILITY(U,$J,358.3,23122,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,23122,1,3,0)
+104 ;;=3^Visospatial Deficit Following Cerebvasc Disease
+105 ;;^UTILITY(U,$J,358.3,23122,1,4,0)
+106 ;;=4^I69.912
+107 ;;^UTILITY(U,$J,358.3,23122,2)
+108 ;;=^5138662
+109 ;;^UTILITY(U,$J,358.3,23123,0)
+110 ;;=I69.913^^78^1000^21
+111 ;;^UTILITY(U,$J,358.3,23123,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,23123,1,3,0)
+114 ;;=3^Psychomotor Deficit Following Cerebvasc Disease
+115 ;;^UTILITY(U,$J,358.3,23123,1,4,0)
+116 ;;=4^I69.913
+117 ;;^UTILITY(U,$J,358.3,23123,2)
+118 ;;=^5138663
+119 ;;^UTILITY(U,$J,358.3,23124,0)
+120 ;;=I69.914^^78^1000^11
